LEADER 03402nam  22005055  450 
001 9910300278103321
005 20200630155701.0
010   $a3-319-68790-5
024 7 $a10.1007/978-3-319-68790-2
035   $a(CKB)4100000002892059
035   $a(MiAaPQ)EBC5439435
035   $a(DE-He213)978-3-319-68790-2
035   $a(PPN)225552957
035   $a(EXLCZ)994100000002892059
100   $a20180328d2018      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aSkin Diseases in the Immunosuppressed /$fedited by Oscar R. Colegio
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (x, 211 pages)
311   $a3-319-68788-3 
327   $aThe Immune System: Structure, Function, and Roles in Skin Disease.- Skin Diseases in Primary Immunodeficiencies -- Skin Diseases Associated with HIV Disease -- Benign Cutaneous Eruptions After Transplantation.- Cutaneous Malignancies in Solid Organ Transplant Recipients.- Skin Diseases Associated with Stem Cell Transplantation.- Skin Cancers Associated With Lymphoid Malignancies.- Skin Diseases Associated with Biologic Therapies.- Virally Induced Cancers.- Immunosenescence and Cutaneous Malignancies.  .
330   $aIn this book, expert dermatologists review state of the art knowledge concerning the clinical presentation and management of cutaneous diseases that develop in immunosuppressed individuals, including transplant recipients, those with primary immunodeficiencies, and HIV sufferers. Throughout the book, correlations are made with iatrogenic, primary, and acquired immunodeficiencies. A major aim is to enable dermatologists to identify the specific immunosuppressant responsible for a specific adverse effect, whether benign or malignant, in patients receiving a complex medication regimen in the setting of transplantation. Further, the book will help the dermatologist to distinguish the cutaneous adverse effects of antiviral agents from effects arising directly from advancing HIV disease. Recognition of the cutaneous manifestations of often less common primary immunodeficiencies will also be emphasized. A final goal is to improve patient outcomes by providing dermatologists with treatment strategies for skin disease arising in the immunosuppressed state. This book will be invaluable for a broad audience, from practicing dermatologists to medical and dermatology residents.
606   $aDermatology
606   $aSurgical transplantation
606   $aImmunology
606   $aDermatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H1900X
606   $aTransplant Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59117
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
615  0$aDermatology.
615  0$aSurgical transplantation.
615  0$aImmunology.
615 14$aDermatology.
615 24$aTransplant Surgery.
615 24$aImmunology.
676   $a616.5079
702   $aColegio$b Oscar R$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300278103321
996   $aSkin Diseases in the Immunosuppressed$91756648
997   $aUNINA